echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Four kinds of drugs were selected into the list of newly added national medical insurance catalogue for online purchase

    Four kinds of drugs were selected into the list of newly added national medical insurance catalogue for online purchase

    • Last Update: 2022-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On March 9, 2022, the Shanghai Pharmaceutical Centralized Bidding and Procurement Office issued a notice on the announcement of some new drugs on the National Medical Insurance Catalogue for online procurement
    .
    According to the notice, Isosorbide Nitrate Glucose Injection, Citicoline Sodium Glucose Injection, Jigucao Capsules, and Xuanfeibaidu Granules were selected
    .
    The original text is as follows: Notice on Announcement of Online Purchase of Some Newly Added National Medical Insurance List Drugs Hu Yaoshi Drug [2022] No.
    17 Release Date: 2022-03-09 "Notice on the Work of Linking to the Internet", the notice on the online procurement of some drugs added to the national medical insurance list in 2021 is as follows: 1.
    Drug information will be announced on March 9, 2022 by the "Shanghai Pharmaceutical Procurement Service and Supervision Information System" Push drug information to hospitals, effective March 11, 2022
    .
    Drugs linked to the Internet are purchased in accordance with the current relevant regulations
    .
    2.
    Verification of drug information After the announcement of drug information, all drug manufacturers are requested to check their own drug information, and if there is any doubt, they should report the situation to the Municipal Pharmaceutical Office in a timely manner
    .
    hereby notified
    .
    Attachment: 1.
    List of information about some newly added drugs in the medical insurance catalogue (the second batch) 2.
    List of information about some newly added drugs under negotiation of medical insurance (the fourth batch) Shanghai Pharmaceutical Centralized Bidding and Purchasing Office March 2022 9th
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.